Gibney Anthony S 4
4 · Aura Biosciences, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Aura (AURA) CFO Anthony Gibney Sells 12,824 Shares
What Happened
Anthony S. Gibney, Chief Financial and Business Officer of Aura Biosciences (AURA), reported a sale of 12,824 shares on 2026-06-16. The shares were disposed at $6.42 each, totaling about $82,330. The filing indicates these shares were sold to satisfy tax withholding obligations tied to vested restricted stock units (RSUs) and were automatic—not at the reporting person's discretion.
Key Details
- Transaction date: 2026-06-16; Sale price: $6.42 per share; Shares sold: 12,824; Proceeds ≈ $82,330.
- Transaction type: Sale (reported as "Open market or private sale," code S).
- Footnote: Sales were automatic to cover tax withholding for RSU vesting (not a discretionary sale).
- Shares owned after the transaction: Not specified in the provided filing excerpt.
- Filing date: 2026-06-16 (filed same day as the transaction — timely filing).
Context
Sales to cover tax withholding on vested RSUs are routine administrative transactions and do not necessarily indicate a change in the insider's view of the company. For retail investors, purchases by insiders typically carry more weight as a bullish signal; routine tax-withholding sales are common and often unrelated to company performance.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-16$6.42/sh−12,824$82,330→ 265,354 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.